EndoChoice receives "strong buy" rating, FDA warns against AbbVie's Hep C drugs — 4 GI/endoscopy company key notes

Here are four recent news updates on gastroenterology and endoscopy companies.

Rebiotix, a Minnesota-based biotechnology company, and McMaster Children's Hospital, based in Ontario, Canada, have started the PediFETCh clinical trial.

NDS Surgical Imaging received the 2015 Excellence in Surgical Products Award.

EndoChoice stock earned a "strong buy" rating from four analysts.

The FDA has issued a safety communication regarding Viekira Pak and Technivie, which are hepatitis C treatments manufactured by AbbVie.

More articles on GI/endoscopy:

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

ASC_GI_300x250

Featured Webinars

Featured Whitepapers

Featured Podcast